Novo’s CEO is in no rush to find his replacement

The next head of Novo Nordisk’s European business is likely to come from outside the company ranks, but CEO Lars Fruergaard is in no rush to find the executive to take up his old position. Increased uncertainty in the US means the group is preparing for a dip in sales for the first time in decades.

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us free for 14 days

Try a trial subscription for free access to our quality journalism

Frontpage right now

Dansk epilepsialarm er blevet solgt til USA

Selskabet Ictalcare, der har Coloplast i ejerkredsen og har udviklet en særlig epilepsialarm, har solgt sine aktiver til et amerikansk selskab. Det er konklusionen på en strategisk proces, som har varet i flere år.

Latest Top picks in English

Related articles